Patients undergoing anti-cancer treatment that incorporates intravenous and oral agents may experience compound adverse effects and challenges related to treatment adherence. Through a national mixed-methods study, ACCC is assessing how care coordination may be improved for these patients. Read more from Oncology Nurse Advisor.
Posted 10/21/2022
Understanding both the benefits to be had from offering BsAb therapy to its community and the scope of this undertaking, Vanderbilt-Ingram Cancer Center took a novel approach with its APP-led BsAb step-up dosing clinic, which won the program a 2026 ACCC Innovator Award.
